Skip to main content
. 2014 Aug 19;24(4):1408–1418. doi: 10.1007/s00044-014-1220-9

Table 2.

Anticancer activity (IC50) of selected compounds 4 and 13 and cisplatin as a reference drug against cancer lines SW-948 and L-1210

Compound IC50 (μg/ml)
SW-948 L-1210
4 5.47 7.41
13 14.95 6.03
Cisplatin 5.52 2.13